Quantification of platelets obtained by different centrifugation protocols in SHR rats  by Yazigi Junior, João Alberto et al.
OQ
c
J
M
U
a
A
R
A
A
K
P
C
P
a
h
2r e v b r a s o r t o p . 2 0 1 5;5 0(6):729–738
www.rbo.org .br
riginal Article
uantiﬁcation  of  platelets  obtained  by different
entrifugation protocols  in SHR  rats
oão Alberto Yazigi Junior ∗, João Baptista Gomes dos Santos, Bruno Rodrigues Xavier,
arcela Fernandes, Sandra Gomes Valente, Vilnei Mattiolli Leite
niversidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 28 September 2014
ccepted 16 December 2014
vailable online 20 October 2015
eywords:
latelet count
entrifugation
latelet-rich plasma
a  b  s  t  r  a  c  t
Objective: To quantify the platelet concentration in the blood of SHR rats, by means of differ-
ent  centrifugation protocols, and to evaluate what the most effective method for obtaining
platelets is.
Methods: We  used 40 male rats of the isogenic SHR lineage. The animals were divided into
three groups: control, using whole blood without centrifugation; single centrifugation, using
whole blood subjected to a single centrifugation at 200 × g and 400 × g; and double cen-
trifugation, using whole blood subjected one centrifugation at different rotations, followed
by  collection of whole plasma subjected to another centrifugation at different rotations:
200  × g + 200 × g; 200 × g + 400 × g; 200 × g + 800 × g; 400 × g + 400 × g; 400 × g + 800 × g. Samples
of  3 ml of blood were drawn from each animal by means of cardiac puncture. The blood was
stored in Vacutainer collection tubes containing 3.2% sodium citrate. The blood from the
control group animals was analyzed without being subjected to centrifugation. After the
blood from the other groups of animals had been subjected to centrifugation, the whole
plasma was collected and subjected to platelet counting in the lower third of the sample.
Results: We  obtained greatest platelet enrichment in the subgroup with two  centrifugations
comprising 400 × g for 10 min + 400 × g for 10 min, in which the mean platelet concentration
was  11.30 times higher than that of the control group.
Conclusion: It was possible to obtain a high platelet concentration using viable simple tech-
niques, by means of centrifugation of whole blood and use of commonly used materials. The
most effective method for obtaining platelet concentrate was found in samples subjected
to  two centrifugations.© 2015 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda. All rights reserved. Study carried out at the Laboratory of Microsurgery of the Discipline of Hand and Upper Limb Surgery, Department of Orthopedics
nd  Traumatology, Universidade Federal de São Paulo (Unifesp), São Paulo, SP, Brazil.
∗ Corresponding author.
E-mail: junioryazigi73@yahoo.com.br (J.A. Yazigi Junior).
ttp://dx.doi.org/10.1016/j.rboe.2015.10.008
255-4971/© 2015 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora Ltda. All rights reserved.
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Quantiﬁcac¸ão do  número  de  plaquetas  a  partir  de  diferentes  métodos  de
centrifugac¸ão  em  ratos  da  linhagem  SHR
Palavras-chave:
Contagem de plaquetas
Centrifugac¸ão
Plasma rico em plaquetas
r  e  s  u  m  o
Objetivo: Quantiﬁcar a concentrac¸ão de plaquetas do sangue de ratos SHR, por meio de
diferentes protocolos de centrifugac¸ão, e avaliar qual o método mais eﬁcaz de obtenc¸ão de
plaquetas.
Métodos: Usamos 40 ratos machos da linhagem isogênica SHR. Os animais foram divididos
em  três grupos: Controle (GCT) - sangue total sem centrifugac¸ão; Única Centrifugac¸ão (GUC)
-  sangue total submetido a uma única centrifugac¸ão: 200 g e 400 g; Dupla Centrifugac¸ão
(GDC)  - sangue total submetido a uma centrifugac¸ão, seguido de coleta do plasma total, e
realizado uma centrifugac¸ão, em diferentes rotac¸ões: 200 g + 200 g; 200 g + 400 g; 200 g + 800 g;
400  g + 400 g; 400 g + 800 g. Foram retirados 3 ml de sangue de cada animal por meio de punc¸ão
cardíaca. O sangue foi acondicionado em tubo de coleta vacutainer com citrato de sódio 3,2%.
O  sangue dos animais do grupo controle não foi submetido à centrifugac¸ão e foi analisado.
Após  a centrifugac¸ão do sangue dos animais, submetido à centrifugac¸ão, o plasma total foi
coletado e submetido à contagem de plaquetas no terc¸o inferior da amostra.
Resultados: Obtivemos maior enriquecimento de plaquetas no subgrupo de duas
centrifugac¸ões (400 g por 10 minutos + 400 g por 10 minutos), no qual ocorreu uma
concentrac¸ão média de plaquetas 11,30 vezes superior em relac¸ão ao grupo controle.
Conclusão: Foi possível obter uma alta concentrac¸ão plaquetária, com técnica simples e
viável, por meio de centrifugac¸ão do sangue total e uso de materiais de uso corriqueiro; e
método mais eﬁcaz de obtenc¸ão de concentrado de plaquetas ocorreu nas amostras sub-
metidas a duas centrifugac¸ões.
© 2015 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
Editora Ltda. Todos os direitos reservados.Introduction
Platelets are cytoplasmic anucleate fragments found in blood
and produced by megakaryocytes in the bone marrow.1,2 Of
the total number of platelets present in the body, 70% are
present in the circulation and 30% in the spleen, remaining
in the circulation for an average of 10 days, when they are
removed by the reticuloendothelial cells of the spleen and
liver.1–3 Platelets are directly involved in several major dis-
eases, as in severe thrombotic syndromes or conditions such
as arterial thrombosis.4,5
The hemostatic system is inherently responsible for the
maintenance of blood ﬂow and vascular integrity, as it is able
to form a plug over a damaged surface of the vascular endothe-
lium when it suffers an injury. Thus, hemostasis minimizes
blood loss and promotes the restoration of the normal vascular
architecture.6–8
The platelet-rich plasma (PRP) is the autologous platelet
concentration in a small volume of plasma, obtained by cen-
trifugation of whole blood, considered an important source of
growth factors. Its basic constitution is given by three com-
ponents: plasma, leukocytes and platelets. The platelet-rich
ﬁbrin (PRF) is a platelet concentrate, obtained from ﬁbrin
membrane, with high potential for tissue regeneration. Thus,
as in PRP, platelet concentrates contained in the PRF release
growth factors (GFs) that enhance the regeneration process.
Additionally, the ﬁbrin matrix promotes angiogenesis, facili-
tates the access to the injured site, with an important role in
tissue healing.9Described for the ﬁrst time in France in 2000,9 platelet-rich
ﬁbrin (PRF), a new concept and still little described in the treat-
ment using ﬁbrin gel, is a platelet concentrate over a ﬁbrin
membrane with a high potential for injury repair. The mem-
brane is obtained from autologous blood without the addition
of external factors.10
It is known that platelets act in the process of hemostasis,
injury healing and reepithelialization, release several growth
factors and that at least seven different GF were identiﬁed
in the initial phase of injury healing. Therefore, the release
of these GF by platelet -granules plays an important role in
the control and proliferation of mesenchymal cells, includ-
ing ﬁbroblasts. PRP is activated by adding calcium ions, with
the release of GF and the exocytosis of -granules and trans-
forms ﬁbrinogen into ﬁbrin. Through this process, we  also
obtain autologous ﬁbrin glue, also called platelet gel or PRP
gel. The PRP gel presentation facilitates its use and han-
dling in several surgical areas and promotes the integration
of ﬂaps and grafts, such as bone, skin, cartilage or fat cells.
The use results in more  rapid and efﬁcient healing, due to
adhesion effect of the gel, which is proportional to the present
ﬁbrinogen.11–13
Obtaining PRP and PRF is relatively simple and has a low
cost. These platelet concentrates provide autologous treat-
ments with the potential to stimulate the natural biological
process of healing and assist in the regeneration of different
tissues. The basic difference between obtaining PRP and PRF
is that, to obtain platelet-rich plasma, a tube with anticoag-
ulant is used (sodium citrate or EDTA 3.2%), while the blood
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Fig. 1 – Plasma collection in the 1.5 mL  Eppendorf tube.
(r e v b r a s o r t o p . 2
hould be collected in a dry tube to obtain platelet-rich ﬁb-
in.
There are several available PRP preparation systems using
 benchtop centrifuge, but in preclinical and clinical stud-
es, the attained results seem contradictory. There is a lack of
ore systematic and consistent studies on the subject, which
akes PRP preparation remain an experimental procedure,
espite its promising application in tissue regeneration.
Calixto,14 when studying the human blood, veriﬁed that
he best method of obtaining PRP is the one in which a single
entrifugation is made, of 200 × g for 10 min. Pereira,15 using
even protocols to obtain PRP in horses, veriﬁed that the higher
he g force and the longer the centrifugation time, the higher
as  the total platelet concentration.
As the animals most often used in research laboratories
re rats and due to the lack of studies in this animal model,
e decided to perform this study to evaluate the best method
o obtain the best platelet concentration, in different pro-
ocols, to quantify the concentration of blood platelets in
HR rats, using different centrifugation protocols and eval-
ate what the most effective method is to obtain platelet
oncentrate.
aterials  and  methods
he work was performed in the Laboratory of Microsurgery of
he Hand and Upper Limb Surgery Discipline of the Depart-
ent of Orthopedics and Traumatology and at the Laboratory
f Hematology of the Department of Clinical and Toxicologi-
al Analyses of our institution. The study was approved by the
esearch Ethics Committee (REC n. 0312/12).
A total of 40 male rats of the isogenic SHR lineage were
sed in the study, weighing 280–300 g, provided by Centro de
esenvolvimento de Modelos Experimentais para Medicina
 Biologia. The animals were kept in collective cages in the
ivarium, with 5 rats in each, in a controlled light-dark cycle
nvironment (12/12 h), temperature of 21 ± 2 ◦C, free access to
ater and food throughout the entire study period.
The animals were divided into three groups:
(1) Control Group (CTG) – whole blood without centrifugation
n = 5).
(2) Single Centrifugation Group (SCG) – whole blood subjected
o a single centrifugation. This group was divided into two
ubgroups:
(a) SCG-I: 200 × g centrifugation for 10 min  (n = 5)
b) SCG-II: 400 × g centrifugation for 10 min  (n = 5)
(3) Double Centrifugation Group (DCG) – whole blood sub-
ected to centrifugation, followed by whole plasma collection
nd subjected to a second centrifugation at different rotations.
his group was divided into ﬁve subgroups:
a) DCG-I: centrifugation at 200 × g for 10 min, followed by a
second 200 × g centrifugation for 10 min  (n = 5)b) DCG-II: 200 × g centrifugation for 10 min, followed by a sec-
ond centrifugation at 400 × g for 10 min  (n = 5)
(c) DCG-III 200 × g centrifugation for 10 min, followed by a sec-
ond centrifugation for 10 min  at 800 × g (n = 5)d) DCG-IV 400 × g centrifugation for 10 min, followed by a sec-
ond centrifugation for 10 min  at 400 × g (n = 5)
(e) DCG-V: 400 × g centrifugation for 10 min, followed by a sec-
ond centrifugation for 10 min  at 800 × g (n = 5)
Blood  and  plasma  sample  collection
The animals were anesthetized with an intraperitoneal injec-
tion with anesthetic solution consisting of xylazine 1 U/100 g
and ketamine 1 U/100 g.
After being anesthetized, 3 ml  of blood was withdrawn
from each animal by cardiac puncture. The collected blood
was placed in a vacutainer tube with sodium citrate at 3.2%.
The blood of the animals from the control group was not
submitted to centrifugation and was analyzed after shaking
the tube for 2 min  at 4 ◦C for homogenization.
Samples of whole animal blood were centrifuged accord-
ing to the protocol described above for each group in a bench
centrifuge (Eppendorf 5810 R) at 4 ◦C.
After centrifugation, the animals’ blood was subjected to a
single centrifugation and the whole plasma was collected into
a 1.5 mL  Eppendorf tube and subjected to platelet counting in
the lower third of the sample.
For the animals’ blood subjected to two  centrifugations,
after the ﬁrst centrifugation the whole plasma was collected
in a 1.5 mL Eppendorf tube and subjected to another centrifu-
gation. The platelet count was performed in the lower third of
the sample (Fig. 1).
Platelet  count
The obtained samples were subjected to platelet count in a
hematology analyzer (Animal Blood Counter – Vet ABC) cali-
brated for blood parameters of rats (Fig. 2).
Statistical  methodsThe resulting hematological parameters, according to the sub-
groups using summary measures (mean, standard deviation,
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Table 1 – Description of resulting hematological parameters.
Variable Group Mean SD Median Minimum Maximum N p
Leukocytes CTRL 3060 219.1 3200 2700 3200 5 0.016
200 × g-10 min 420 465.8 200 100 1200 5
400 × g-10 min 420 549.5 200 100 1400 5
200 × g-10 min + 200 × g-10 min 1160 2260.1 100 100 5200 5
200 × g-10 min + 400 × g-10 min 1860 1105.9 1400 500 3100 5
200 × g-10 min + 800 × g-10 min 2.700 3755.7 700 300 9200 5
400 × g-10 min + 400 × g-10 min 3.020 2983.6 1500 400 7800 5
400 × g-10 min + 800 × g-10 min 3160 3943.7 500 200 8700 5
Erythrocytes CTRL 7,120,000 358,956.8 7,020,000 6.640.000 7,530,000 5 <0.001
200 × g-10 min 22,000 16,431.7 20,000 10,000 50,000 5
400 × g-10 min 14,000 11,401.8 10,000 0 30,000 5
200 × g-10 min + 200 × g-10 min 80,000 134,721.9 20,000 10,000 320,000 5
200 × g-10 min + 400 × g-10 min 262,000 895,545 240,000 150,000 380,000 5
200 × g-10 min + 800 × g-10 min 170,000 101,242.3 150,000 60,000 330,000 5
400 × g-10 min + 400 × g-10 min 120,000 86,313.4 150,000 20,000 220,000 5
400 × g-10 min + 800 × g-10 min 188,000 199,549.5 70,000 10,000 420,000 5
Platelets CTRL 648,800 30,094.9 648,000 614,000 695,000 5 0.013
200 × g-10 min 1,632,400 580,962.4 1650.000 682,000 2,122,000 5
400 × g-10 min 939,600 687,417.1 863,000 110,000 1,764,000 5
200 × g-10 min + 200 × g-10 min 3,826,000 4920.808.4 456,000 29,000 970.0000 5
200 × g-10 min + 400 × g-10 min 4,760,000 2254.550.953 530.0000 130.0000 720.0000 5
200 × g-10 min + 800 × g-10 min 4,080,000 1685.823,241 310.0000 270.0000 6500.000 5
400 × g-10 min + 400 × g-10 min 7,320,000 2819.929,077 7,300,000 2,800,000 9,700,000 5
400 × g-10 min + 800 × g-10 min 5,500,000 1813.835,715 5200.000 3400.000 7600.000 5
Plasma volume (mL) CTRL 0 0 0 0 0 5 <0.001
200 × g-10 min 0.72 0.11 0.8 0.6 0.8 5
400 × g-10 min 1.10 0.10 1.1 1 1.2 5
200 × g-10 min + 200 × g-10 min 1.46 0.11 1.5 1.3 1.6 5
200 × g-10 min + 400 × g-10 min 1.60 0.10 1.6 1.5 1.7 5
200 × g-10 min + 800 × g-10 min 1.62 0.04 1.6 1.6 1.7 5
400 × g-10 min + 400 × g-10 min 1.62 0.08 1.6 1.5 1.7 5
400 × g-10 min + 800 × g-10 min 1.72 0.08 1.7 1.6 1.8 5
Kruskal–Wallis test result.
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edian, minimum and maximum) were compared to the sub-
roups using Kruskal–Wallis tests followed by Dunn’s multiple
on-parametric comparisons, when necessary to compare the
ubgroups two by two.
esults
he results were depicted using tables and bar charts that rep-
esent the median values of each parameter according to the
ubgroups; the tests were performed with a signiﬁcance level
f 5%.
Table 1 shows that all assessed parameters showed statis-
ically signiﬁcant difference between the groups (p < 0.05).
Figs. 3 and 4 suggest higher amounts of leukocytes and
rythrocytes in the control group.Fig. 5 shows that the highest platelet enrichment occurred
n the subgroup of two 400 × g + 400 × g centrifugations.
The plasma volume values shown in Fig. 6 are higher with
wo centrifugations (400 × g for 10 min  + 800 × g for 10 min).
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Table 2 shows that the resulting amount of leukocytes was
statistically higher in the control group when compared to the
subgroups with a single centrifugation (p = 0.004 and p = 0.004)
and in relation to the subgroup with two 200 × g centrifu-
gations and 10 min  each (p = 0.007). On the other hand, the
subgroup with two 400 × g centrifugations and 10 min  each
showed statistically more  leukocytes than the subgroups with
a single centrifugation (p < 0.05) and the subgroup with two
200 × g centrifugations and 10 min  each (p = 0.031).
Table 3 shows that the amount of red blood cells was
statistically higher in the control than in the other sub-
groups (p < 0.05), with the exception of the subgroups with two
centrifugations of 200 × g-10 min  + 400 × g-10 min  and 200 × g-
10 min  + 800 × g-10 min  (p = 0.192 and p = 0.056). These two
subgroups showed statistically more  red blood cells than the
subgroups of a single centrifugation and subgroups of two
200 × g centrifugations and 10 min  each (p < 0.05).
Table 4 shows that the amount of platelets with two  cen-
trifugations was statistically higher than the control, with a
single centrifugation, and the subgroup with two centrifuga-
tions, with 200 × g and 10 min  each (p < 0.05).
Table 5 shows that the obtained plasma volume was statis-
tically similar to the behavior of platelets. Subgroups with two
centrifugations have higher volume than the other subgroups,
except for the subgroup with two centrifugations, with 200 × g
and 10 min  each.
The tables and ﬁgures show that the amount of platelets
with two centrifugations (400 × g + 400 × g subgroup) was
statistically higher than the control with only a single centrifu-
gation, whereas the subgroup with two centrifugations, with
200 × g and 10 min  each (p < 0.05) showed a mean concentra-
tion of platelets (400 × g + 400 × g) that was 11.30-fold higher
compared to the control group.Discussion
The literature shows techniques to obtain platelet-rich
plasma, as the ﬁrst one used, only applicable in a hospital
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structure with plasmapheresis machine that requires a tech-
nician to manipulate it.16 The procedure had higher morbidity
and required sophisticated technology.
The search for techniques to obtain PRP with lower costs
has led to the use of some simple methods with test tubes
and a common centrifuge, which allow the preparation of
platelet-rich plasma at a much lower cost and in an out-
patient setting. However, these methods are laborious and
require learning from those who will perform the proce-
dure.
The existing methods in the literature do not reach
the same platelet concentrations. Some are insufﬁcient to
improve tissue regeneration. These factors may explain much
of the criticism about the effectiveness and applicability of
platelet-rich plasma.
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Another key factor is associated with the anticoagulant.
Usually, sodium citrate 3.2% is used. The sodium citrate cap-
tures calcium ions from blood and neutralized them, forming
a compound named chelate that prevents clot formation.
Additionally, the sodium citrate does not alter the platelet
membrane receptors and, consequently, the chelation process
can be reversed by the addition of calcium chloride to form
platelet gel.17
The recent technology allows the use of PRP with small
blood volumes, thus minimizing the need for red blood cell
reinfusion and associated risks. However, there is little infor-
mation about the optimal amount of platelets for better tissue
repair.
The literature shows several protocols for obtaining PRP.
The number of centrifugations (one or two) will depend on the
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ethod to be used. Some authors suggest only one centrifuga-
ion, while other references indicate a double centrifugation
rotocol.
Any protocol to obtain the PRP should concentrate platelets
t its maximum to correspond to the clinical results reported
Table 2 – Results of multiple leukocyte comparisons.
Leukoc
Comparison 
CTRL VS 200 × g-10 min 
CTRL VS 400 × g-10 min 
CTRL VS 200 × g-10 min + 20
CTRL VS 200 × g-10 min + 40
CTRL VS 200 × g-10 min + 80
CTRL VS 400 × g-10 min + 40
CTRL VS 400 × g-10 min + 80
200 × g-10 min VS 400 × g-10 min 
200 × g-10 min VS 200 × g-10 min + 20
200 × g-10 min VS 200  × g-10 min + 40
200 × g-10 min VS 200 × g-10 min + 80
200 × g-10 min VS 400 × g-10 min + 40
200 × g-10 min VS 400 × g-10 min + 80
400 × g-10 min VS 200 × g-10 min + 20
400 × g-10 min VS 200 × g-10 min + 40
400 × g-10 min VS 200 × g-10 min + 80
400 × g-10 min VS 400 × g-10 min + 40
400 × g-10 min VS 400 × g-10 min + 80
200 × g-10 min + 200 × g-10 min VS 200 × g-10 min + 40
200 × g-10 min + 200 × g-10 min VS 200 × g-10 min + 80
200 × g-10 min + 200 × g-10 min VS 400 × g-10 min + 40
200 × g-10 min + 200 × g-10 min VS 400 × g-10 min + 80
200 × g-10 min + 400 × g-10 min VS 200 × g-10 min + 80
200 × g-10 min + 400 × g-10 min VS 400 × g-10 min + 40
200 × g-10 min + 400 × g-10 min VS 400 × g-10 min + 80
200 × g-10 min + 800 × g-10 min VS 400 × g-10 min + 40
200 × g-10 min + 800 × g-10 min VS 400 × g-10 min + 80
400 × g-10 min + 400 × g-10 min VS 400 × g-10 min + 80
Dunn’s multiple comparison test results.a volume values.
in the literature. But in addition to a high platelet concentra-
tion with a large release of growth factors, it is very important
that the integrity of platelets is maintained. The growth fac-
tors must be released from viable platelets, as during the
act of granular exocytosis, the platelet completes the tertiary
ytes
Z value p
2.84 0.004
2.84 0.004
0 × g-10 min 2.70 0.007
0 × g-10 min 0.90 0.367
0 × g-10 min 1.04 0.298
0 × g-10 min 0.54 0.589
0 × g-10 min 1.11 0.267
0.00 >0.999
0 × g-10 min −0.14 0.890
0 × g-10 min −1.94 0.052
0 × g-10 min −1.80 0.071
0 × g-10 min −2.30 0.021
0 × g-10 min −1.73 0.083
0 × g-10 min −0.14 0.890
0 × g-10 min −1.94 0.052
0 × g-10 min −1.80 0.071
0 × g-10 min −2.30 0.021
0 × g-10 min −1.73 0.083
0 × g-10 min −1.80 0.071
0 × g-10 min −1.66 0.096
0 × g-10 min −2.16 0.031
0 × g-10 min −1.59 0.111
0 × g-10 min 0.14 0.890
0 × g-10 min −0.36 0.718
0 × g-10 min 0.21 0.835
0 × g-10 min −0.50 0.618
0 × g-10 min 0.07 0.945
0 × g-10 min 0.57 0.570
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Table 3 – Results of multiple erythrocyte comparisons.
Erythrocytes
Comparison Z value p
CTRL VS 200  × g-10 min 3.90 <0.001
CTRL VS 400 × g-10 min 4.27 <0.001
CTRL VS 200 × g-10 min + 200 × g-10 min 3.41 0.001
CTRL VS 200 × g-10 min + 400 × g-10 min 1.30 0.192
CTRL VS 200 × g-10 min + 800 × g-10 min 1.91 0.056
CTRL VS 400 × g-10 min + 400 × g-10 min 2.44 0.015
CTRL VS 400 × g-10 min + 800 × g-10 min 2.18 0.029
200 × g-10 min VS 400 × g-10 min 0.37 0.708
200 × g-10 min VS 200 × g-10 min + 200 × g-10 min −0.49 0.627
200 × g-10 min VS 200 × g-10 min + 400 × g-10 min −2.59 0.010
200 × g-10 min VS 200 × g-10 min + 800 × g-10 min −1.98 0.047
200 × g-10 min VS 400 × g-10 min + 400 × g-10 min −1.46 0.145
200 × g-10 min VS 400 × g-10 min + 800 × g-10 min −1.72 0.086
400 × g-10 min VS 200 × g-10 min + 200 × g-10 min −0.86 0.390
400 × g-10 min VS 200 × g-10 min + 400 × g-10 min −2.97 0.003
400 × g-10 min VS 200 × g-10 min + 800 × g-10 min −2.36 0.018
400 × g-10 min VS 400 × g-10 min + 400 × g-10 min −1.83 0.067
400 × g-10 min VS 400 × g-10 min + 800 × g-10 min −2.09  0.036
200 × g-10 min + 200 × g-10 min VS 200  × g-10 min + 400 × g-10 min −2.11 0.035
200 × g-10 min + 200 × g-10 min VS 200 × g-10 min + 800 × g-10 min −1.50 0.134
200 × g-10 min + 200 × g-10 min VS 400 × g-10 min + 400 × g-10 min −0.97 0.332
200 × g-10 min + 200 × g-10 min VS 400 × g-10 min + 800 × g-10 min −1.23 0.217
200 × g-10 min + 400 × g-10 min VS 200 × g-10 min + 800 × g-10 min 0.61 0.542
200 × g-10 min + 400 × g-10 min VS 400 × g-10 min + 400 × g-10 min 1.14 0.255
200 × g-10 min + 400 × g-10 min VS 400 × g-10 min + 800 × g-10 min 0.87 0.382
200 × g-10 min + 800 × g-10 min VS 400 × g-10 min + 400 × g-10 min 0.53 0.598
200 × g-10 min + 800 × g-10 min VS 400 × g-10 min + 800 × g-10 min 0.26 0.792
400 × g-10 min + 400 × g-10 min VS 400 × g-10 min + 800 × g-10 min −0.26 0.792Dunn’s multiple comparison test results.
Table 4 – Results of multiple platelet comparisons.
Platel
Comparison 
CTRL VS 200 × g-10 min 
CTRL VS 400 × g-10 min 
CTRL VS 200 × g-10 min + 20
CTRL VS 200 × g-10 min + 40
CTRL VS 200 × g-10 min + 80
CTRL VS 400 × g-10 min + 40
CTRL VS 400 × g-10 min + 80
200 × g-10 min VS 400 × g-10 min 
200 × g-10 min VS 200 × g-10 min + 20
200 × g-10 min VS 200 × g-10 min + 40
200 × g-10 min VS 200 × g-10 min + 80
200 × g-10 min VS 400 × g-10 min + 40
200 × g-10 min VS 400 × g-10 min + 80
400 × g-10 min VS 200 × g-10 min + 20
400 × g-10 min VS 200 × g-10 min + 40
400 × g-10 min VS 200 × g-10 min + 80
400 × g-10 min VS 400 × g-10 min + 40
400 × g-10 min VS 400 × g-10 min + 80
200 × g-10 min + 200 × g-10 min VS 200 × g-10 min + 40
200 × g-10 min + 200 × g-10 min VS 200 × g-10 min + 80
200 × g-10 min + 200 × g-10 min VS 400  × g-10 min + 40
200 × g-10 min + 200 × g-10 min VS 400 × g-10 min + 80
200 × g-10 min + 400 × g-10 min VS 200 × g-10 min + 80ets
Z value p
−1.03 0.305
−0.25 0.803
0 × g-10 min −1.19 0.233
0 × g-10 min −2.50 0.013
0 × g-10 min −2.29 0.022
0 × g-10 min −3.48 0.001
0 × g-10 min −2.91 0.004
0.78 0.437
0 × g-10 min −0.17 0.868
0 × g-10 min −1.47 0.142
0 × g-10 min −1.26 0.207
0 × g-10 min −2.45 0.014
0 × g-10 min −1.89 0.059
0 × g-10 min −0.94 0.346
0 × g-10 min −2.25 0.025
0 × g-10 min −2.04 0.041
0 × g-10 min −3.23 0.001
0 × g-10 min −2.66 0.008
0 × g-10 min −1.30 0.192
0 × g-10 min −1.10 0.273
0 × g-10 min −2.29 0.022
0 × g-10 min −1.72 0.086
0 × g-10 min 0.21 0.835
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Table 4 – (Continued)
Platelets
Comparison Z value p
200 × g-10 min + 400 × g-10 min VS 400 × g-10 min + 400 × g-10 min −0.98 0.325
200 × g-10 min + 400 × g-10 min VS 400 × g-10 min + 800 × g-10 min −0.42 0.677
200 × g-10 min + 800 × g-10 min VS 400 × g-10 min + 400 × g-10 min −1.19 0.233
200 × g-10 min + 800 × g-10 min VS 400  × g-10 min + 800 × g-10 min −0.62 0.533
400 × g-10 min + 400 × g-10 min VS 400  × g-10 min + 800 × g-10 min 0.57 0.570
s
c
d
o
c
w
p
b
w
u
h
tDunn’s multiple comparison test results.
tructure of the growth factor proteins. Fragmented platelets
an degranulate large amounts of growth factors, but with
ecreased effectiveness.18
In this study, we  compared the number of platelets
btained from peripheral blood and subjected to one and two
entrifugations; the higher enrichment occurred in the group
ith two centrifugations. The results are similar, when com-
ared to the results of some published studies, such as the one
y Calixto.14
In the study by Calixto,14 carried out in humans, test tubes
ith the anticoagulant sodium citrate at 3.2% and EDTA were
sed, which showed a difference in platelet concentration,
igher when citrate was used. Based on this fact, we  chose
he citrate as the only anticoagulant in the collection tubes.
Table 5 – Results of plasma volume comparisons.
Plasma v
Comparison 
CTRL VS 200 × g-10 min 
CTRL VS 400 × g-10 min 
CTRL VS 200 × g-10 min + 20
CTRL VS 200 × g-10 min + 40
CTRL VS 200 × g-10 min + 80
CTRL VS 400 × g-10 min + 40
CTRL VS 400 × g-10 min + 80
200 × g-10 min VS 400 × g-10 min 
200 × g-10 min VS 200 × g-10 min + 20
200 × g-10 min VS 200 × g-10 min + 40
200 × g-10 min VS 200 × g-10 min + 80
200 × g-10 min VS 400 × g-10 min + 40
200 × g-10 min VS 400 × g-10 min + 80
400 × g-10 min VS 200  × g-10 min + 20
400 × g-10 min VS 200 × g-10 min + 40
400 × g-10 min VS 200 × g-10 min + 80
400 × g-10 min VS 400 × g-10 min + 40
400 × g-10 min VS 400 × g-10 min + 80
200 × g-10 min + 200 × g-10 min VS 200 × g-10 min + 40
200 × g-10 min + 200 × g-10 min VS 200 × g-10 min + 80
200 × g-10 min + 200 × g-10 min VS 400 × g-10 min + 40
200 × g-10 min + 200 × g-10 min VS 400 × g-10 min + 80
200 × g-10 min + 400 × g-10 min VS 200 × g-10 min + 80
200 × g-10 min + 400 × g-10 min VS 400 × g-10 min + 40
200 × g-10 min + 400 × g-10 min VS 400 × g-10 min + 80
200 × g-10 min + 800 × g-10 min VS 400 × g-10 min + 40
200 × g-10 min + 800 × g-10 min VS 400 × g-10 min + 80
400 × g-10 min + 400 × g-10 min VS 400 × g-10 min + 80
Dunn’s multiple comparison test results.Vendramin et al.19obtained platelet-rich plasma of better
quality using two centrifugations at 400 × g for 10 min  + 800 × g
for 10 min. In our study, we  obtained a high platelet concen-
tration with 400 × g + 800 × g; however, the highest amount
of platelets was obtained with 400 × g for 10 min  + 400 × g
for 10 min. This result shows that the lysis of platelets can
occur above this force, which inﬂuences its ﬁnal concentra-
tion.
Several studies were performed in humans, rabbits and
horses; however, we did not ﬁnd centrifugation protocols in
rats. With the establishment of a protocol to obtain PRP in rats,
which reached a high platelet concentration, we  encourage
future studies to evaluate the clinical effectiveness of platelet-
rich plasma. Further studies may emerge from our protocol
olume
Z value p
−0.69 0.488
−1.39 0.166
0 × g-10 min −2.36 0.018
0 × g-10 min −3.38 0.001
0 × g-10 min −3.55 <0.001
0 × g-10 min −3.58 <0.001
0 × g-10 min −4.47 <0.001
−0.69 0.488
0 × g-10 min −1.66 0.096
0 × g-10 min −2.69 0.007
0 × g-10 min −2.86 0.004
0 × g-10 min −2.88 0.004
0 × g-10 min −3.77 <0.001
0 × g-10 min −0.97 0.332
0 × g-10 min −2.00 0.046
0 × g-10 min −2.16 0.031
0 × g-10 min −2.19 0.028
0 × g-10 min −3.08 0.002
0 × g-10 min −1.03 0.305
0 × g-10 min −1.19 0.233
0 × g-10 min −1.22 0.222
0 × g-10 min −2.11 0.035
0 × g-10 min −0.17 0.868
0 × g-10 min −0.19 0.846
0 × g-10 min −1.08 0.279
0 × g-10 min −0.03 0.978
0 × g-10 min −0.92 0.360
0 × g-10 min −0.89 0.375
p . 2 0 
r
1
1
1
1
1
1
1
1
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and expand its use in the regeneration of nerves, tissue, bone
and ligament grafts.
Conclusion
It was possible to obtain a high platelet concentration, using a
simple and feasible technique, through whole blood centrifu-
gation and using common materials such as collection tubes,
syringes and needles. The most effective method to obtain a
platelet concentrate was achieved in the samples subjected
to two centrifugations (400 × g for 10 min  + 400 × g for 10 min),
which yielded a mean platelet concentration that was 11.30-
fold higher than that in the control group.
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